Financial Advantage’s Boston Scientific BSX Stock Holding History

Financial Advantage’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-200	Closed	-$8K	–	123
2022 Q1	$8K	Hold	200	–	–	0.01%	119
2021 Q4	$8K	Hold	200	–	–	0.01%	118
2021 Q3	$8K	Hold	200	–	–	0.01%	103
2021 Q2	$8K	Hold	200	–	–	0.01%	103
2021 Q1	$7K	Hold	200	–	–	0.01%	115
2020 Q4	$7K	Hold	200	–	–	0.01%	104
2020 Q3	$7K	Hold	200	–	–	0.01%	96
2020 Q2	$7K	Hold	200	–	–	0.01%	135
2020 Q1	$6K	Hold	200	–	–	0.01%	96
2019 Q4	$9K	Hold	200	–	–	0.01%	90
2019 Q3	$8K	Hold	200	–	–	0.01%	137
2019 Q2	$8K	Hold	200	–	–	0.01%	92
2019 Q1	$7K	Buy	+200	New	+$7.64K	0.01%	96

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Financial Advantage's BSX Position: Q2 2022 in Review

Financial Advantage sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 200 shares — an estimated $8K sold.

Financial Advantage first reported a position in BSX in Q1 2019 and held it in 13 quarters. The position peaked at $9K in Q4 2019. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

Financial Advantage reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
Financial Advantage sold 200 Boston Scientific shares in Q2 2022, an estimated $8K.
Financial Advantage first reported a position in Boston Scientific in Q1 2019 and held it in 13 quarters.
Financial Advantage's Boston Scientific position peaked at $9K in Q4 2019.
878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Financial Advantage's 13F filing for Q2 2022, filed 1 Aug 2022.